Yeah, they’ll get it of their own accord. They’ll need trial sites etc.
To me this PR appears to be more bravado than substance at this timing, which is fine because that’s what’s needed. It tells the FDA they have confidence and aren’t afraid to prove it. It’s telling to the world ... if they are paying attention.
News 
Market Data 
Discover 
